Nara Lívia Rezende Soares da Paz Oliveira

Nara Lívia Rezende Soares da Paz Oliveira

Auto-generated profile, based on publicly available information

Nara Lívia Rezende Soares da Paz Oliveira

Irmandade da Santa Casa de Misericórdia de São Paulo, São Paulo, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2021 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
DPDébora Martins Ferreira Pessoa
Débora Martins Ferreira Pessoa
NONara Lívia Rezende Soares da Paz Oliveira
Nara Lívia Rezende Soares da Paz Oliveira
GDGiuliane de Santana Dantas
Giuliane de Santana Dantas
VFVania de Fátima Tonetto Fernandes
Vania de Fátima Tonetto Fernandes
RNRenata Maria de Noronha
Renata Maria de Noronha
LCLuis Eduardo Calliari
Luis Eduardo Calliari
Objective: People with Down's syndrome (DS) have a higher risk of developing type 1 diabetes mellitus (T1D) and may have specific clinical features compared to T1D patients without DS. This study evaluated the clinical and laboratory aspects of T1D in children and adolescents with DS in an admixed population. Subjects and methods: A case-control study comparing patients with T1D and DS (T1D+DS) to patients with T1D without DS (T1D controls) from two tertiary academic Hospitals in Sao Paulo, Brazil. Results: The sample consisted of 9 patients with T1D+DS and 18 T1D age and sex -matched controls. Anti-glutamic acid decarboxylase 65 antibodies were positive in 7/7 of the 9 T1D+DS patients, confirming the presence of diabetes autoimmunity in this group. Mean age at diagnosis of T1D was 4.9 +/- 3.9 years in the T1D+DS group and 6.4 years +/- 3 in the T1D control group; early diagnosis (<2 years old) occurred in three T1D+DS patients but only in one T1D control patients, both suggesting lower age of diagnosis in T1D+DS group, although without statistical significance (p = 0.282 and p = 0.093, respectively). The T1D+DS group presented lower total insulin dose (0.7 I11/kg/day +/- 0.2) and HbA1c (7.2% +/- 0.6) than the control group (1.0 I11/kg/day +/- 0.3 and 9.1% +/- 0.7, respectively) (p = 0.022 and p = 0.047, respectively). Conclusion: We confirmed the autoimmune etiology of diabetes in people with DS in this admixed population. T1D+DS patients developed diabetes earlier and achieved better metabolic control with a lower insulin dose than T1D controls. These findings are in agreement with previous studies in Caucasian populations. Arch Endocrinol Metab. 2021;65(5):562-9

10 November 2025 in Annales Médico-psychologiques, revue psychiatrique
Verified
Journal Article
Closed access
PJPetrone Bandeira dos Santos Junior
Petrone Bandeira dos Santos Junior
NONara Lívia Rezende Soares da Paz Oliveira
Nara Lívia Rezende Soares da Paz Oliveira
GOGiuliano da Paz Oliveira
Giuliano da Paz Oliveira